ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.446,94
-0,03%
S&P 500
6.101,24
-0,29%
US Dollar vs BRL
5,9224
0,16%
Bitcoin
101.338,72
-1,29%
Brent Oil
77,165
-0,03%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Eli Lilly And Co (0Q1G)

  7. Eli Lilly And Co (0Q1G) Notícias

0Q1G

Eli Lilly (0Q1G)

Eli Lilly And Co
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:0Q1G
DataHoraFonteTítuloCódigoCompanhia
14/01/202511:33Alliance NewsAlliance NewsEli Lilly shares fall as lowers fourth quarter revenue guidanceLSE:0Q1GEli Lilly And Co
16/12/202404:54Alliance NewsAlliance NewsLSE:0Q1GEli Lilly And Co
26/11/202403:42Alliance NewsAlliance NewsNovo Nordisk diabetes and obesity drugs also protect kidneys — studyLSE:0Q1GEli Lilly And Co
30/10/202409:24Alliance NewsAlliance NewsTOP NEWS: Eli Lilly returns to profit in quarter, downgrades guidanceLSE:0Q1GEli Lilly And Co
09/09/202408:16Alliance NewsAlliance NewsEli Lilly names Lucas Montarce as new chief financial officerLSE:0Q1GEli Lilly And Co
08/08/202408:57Alliance NewsAlliance NewsTOP NEWS: Eli Lilly lifts guidance as Mounjaro and Zepbound sales jumpLSE:0Q1GEli Lilly And Co
08/07/202415:58Alliance NewsAlliance NewsEli Lilly weight loss drug beats Ozempic in head-to-head studyLSE:0Q1GEli Lilly And Co
05/06/202410:00Alliance NewsAlliance NewsTOP NEWS: Alphabet poaches Eli Lilly CFO Anat Ashkenazi for same roleLSE:0Q1GEli Lilly And Co
21/05/202409:14Alliance NewsAlliance News*Eli Lilly: over half of Crohn's disease patients reach remission at 1 year w/ mirikzumabLSE:0Q1GEli Lilly And Co
15/05/202417:07Alliance NewsAlliance NewsEli Lilly reaches settlement with Totality MedispaLSE:0Q1GEli Lilly And Co
30/04/202409:26Alliance NewsAlliance NewsTOP NEWS: Eli Lilly lifts outlook, ramps up production to meet demandLSE:0Q1GEli Lilly And Co
08/03/202412:16Alliance NewsAlliance NewsEli Lilly's Donanemab Alzheimer's drug hit by delaysLSE:0Q1GEli Lilly And Co
06/02/202409:44Alliance NewsAlliance NewsTOP NEWS: Eli Lilly eyes beefier sales amid weight loss drug crazeLSE:0Q1GEli Lilly And Co
26/01/202403:04Alliance NewsAlliance NewsEli Lilly weight loss drug could be supplied to UK 'in weeks'LSE:0Q1GEli Lilly And Co
23/01/202415:48Alliance NewsAlliance NewsIN BRIEF: Eli Lilly hails upbeat trial data for hearing loss therapyLSE:0Q1GEli Lilly And Co
17/11/202311:18Alliance NewsAlliance NewsTOP NEWS: Eli Lilly to invest USD2.5 billion in GermanyLSE:0Q1GEli Lilly And Co
09/11/202303:09Alliance NewsAlliance NewsEli Lilly diabetes drug authorised for weight management, loss in UKLSE:0Q1GEli Lilly And Co
08/11/202317:15Alliance NewsAlliance NewsUS approves highly anticipated Eli Lilly weight loss drugLSE:0Q1GEli Lilly And Co
02/11/202308:42Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts yearly outlook on chunky R&D costsLSE:0Q1GEli Lilly And Co
08/08/202308:23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly second quarter profit up, notes pipeline successesLSE:0Q1GEli Lilly And Co
21/06/202315:34Alliance NewsAlliance NewsUS FDA approves Eli Lilly's Jardiance drug for diabetes in childrenLSE:0Q1GEli Lilly And Co
27/04/202309:28Alliance NewsAlliance NewsTOP NEWS: Eli Lilly quarterly revenue down on reduced Covid-19 demandLSE:0Q1GEli Lilly And Co
03/03/202318:20Alliance NewsAlliance NewsIN BRIEF: US FDA approves expanded indication for Eli Lilly's VerzenioLSE:0Q1GEli Lilly And Co
01/03/202310:42Alliance NewsAlliance NewsUS drugmaker Eli Lilly says slashing insulin prices by 70%LSE:0Q1GEli Lilly And Co
02/02/202317:17Alliance NewsAlliance NewsEli Lilly & Co sees quarterly revenue fall amid declining volumesLSE:0Q1GEli Lilly And Co
01/11/202213:24Alliance NewsAlliance NewsEli Lilly lowers full year guidance despite positive earnings figuresLSE:0Q1GEli Lilly And Co
04/08/202208:23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts annual guidance as second quarter disappointsLSE:0Q1GEli Lilly And Co
03/02/202212:17Alliance NewsAlliance NewsEli Lilly sees net income fall but outlook for 2022 remains unchangedLSE:0Q1GEli Lilly And Co
 Apresentando as notícias mais relevantes sobre:LSE:0Q1G

Seu Histórico Recente

LSE
40AA
Anz Bank 43
NYSE
TGS
Transportadora De Gas De...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados